• Je něco špatně v tomto záznamu ?

Negative prognostic significance of primary cilia and cytoplasmic β-catenin expression in non-small cell lung cancer

B. Rosova, A. Filipova, D. Hadzi Nikolov, M. Drösslerova, R. Matej, A. Rozsypalova, I. Richter, B. Melichar, R. Mahel, R. Stepanova, R. Lohynska, J. Dvorak

. 2024 ; 71 (6) : 594-602. [pub] -

Jazyk angličtina Země Slovensko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010579

The objective of this study was to investigate the prognostic significance of the frequency of primary cilia (PC) and β-catenin expression in 218 patients (pts) with non-small cell lung cancer (NSCLC), including 125 pts with adenocarcinoma and 93 pts with squamous cell carcinoma. In the whole group of 218 pts with NSCLC, overall survival (OS) was significantly inferior among pts with present PC than without PC (p=0.024) and with higher cytoplasmic β-catenin expression (25-75%) than with lower cytoplasmic β-catenin expression (<25%) (p=0.008). In the univariate Cox proportional hazard model, the hazard ratio was 1.653 in pts with present PC (p=0.026) and 1.851 in pts with higher cytoplasmic β-catenin (25-75%) (p=0.009). Multivariate testing of the whole group of 218 pts with NSCLC showed that the presence of PC was associated with a worse prognosis (p=0.018). In the subgroup of 125 pts with adenocarcinoma, OS was significantly improved in pts with higher membranous β-catenin expression (≥50%) than in pts with lower expression (<50%) (p=0.0300) and OS was significantly inferior in pts with higher cytoplasmic β-catenin expression (25-75%) than in pts with lower expression (<25%) (p=0.0004). Multivariate testing of the subgroup of pts with adenocarcinoma showed that cytoplasmic β-catenin (p<0.001) and pleural invasion (p=0.017) were associated with worse prognosis. The present results indicate a negative prognostic significance of PC and cytoplasmic β-catenin expression in NSCLC and a negative prognostic significance of cytoplasmic β-catenin expression in adenocarcinoma.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010579
003      
CZ-PrNML
005      
20250429134747.0
007      
ta
008      
250415s2024 xo f 000 0|eng||
009      
AR
024    7_
$a 10.4149/neo_2024_241117N476 $2 doi
035    __
$a (PubMed)39832204
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Rosova, Blanka $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
245    10
$a Negative prognostic significance of primary cilia and cytoplasmic β-catenin expression in non-small cell lung cancer / $c B. Rosova, A. Filipova, D. Hadzi Nikolov, M. Drösslerova, R. Matej, A. Rozsypalova, I. Richter, B. Melichar, R. Mahel, R. Stepanova, R. Lohynska, J. Dvorak
520    9_
$a The objective of this study was to investigate the prognostic significance of the frequency of primary cilia (PC) and β-catenin expression in 218 patients (pts) with non-small cell lung cancer (NSCLC), including 125 pts with adenocarcinoma and 93 pts with squamous cell carcinoma. In the whole group of 218 pts with NSCLC, overall survival (OS) was significantly inferior among pts with present PC than without PC (p=0.024) and with higher cytoplasmic β-catenin expression (25-75%) than with lower cytoplasmic β-catenin expression (<25%) (p=0.008). In the univariate Cox proportional hazard model, the hazard ratio was 1.653 in pts with present PC (p=0.026) and 1.851 in pts with higher cytoplasmic β-catenin (25-75%) (p=0.009). Multivariate testing of the whole group of 218 pts with NSCLC showed that the presence of PC was associated with a worse prognosis (p=0.018). In the subgroup of 125 pts with adenocarcinoma, OS was significantly improved in pts with higher membranous β-catenin expression (≥50%) than in pts with lower expression (<50%) (p=0.0300) and OS was significantly inferior in pts with higher cytoplasmic β-catenin expression (25-75%) than in pts with lower expression (<25%) (p=0.0004). Multivariate testing of the subgroup of pts with adenocarcinoma showed that cytoplasmic β-catenin (p<0.001) and pleural invasion (p=0.017) were associated with worse prognosis. The present results indicate a negative prognostic significance of PC and cytoplasmic β-catenin expression in NSCLC and a negative prognostic significance of cytoplasmic β-catenin expression in adenocarcinoma.
650    _2
$a lidé $7 D006801
650    12
$a nemalobuněčný karcinom plic $x patologie $x metabolismus $x mortalita $7 D002289
650    12
$a beta-katenin $x metabolismus $7 D051176
650    _2
$a prognóza $7 D011379
650    12
$a nádory plic $x patologie $x metabolismus $x mortalita $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a cilie $x patologie $x metabolismus $7 D002923
650    _2
$a senioři $7 D000368
650    _2
$a lidé středního věku $7 D008875
650    12
$a cytoplazma $x metabolismus $7 D003593
650    _2
$a adenokarcinom $x patologie $x metabolismus $x mortalita $7 D000230
650    _2
$a spinocelulární karcinom $x patologie $x metabolismus $x mortalita $7 D002294
650    _2
$a dospělí $7 D000328
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a senioři nad 80 let $7 D000369
655    _2
$a časopisecké články $7 D016428
700    1_
$a Filipova, Alzbeta $u Department of Radiobiology, Military Faculty of Medicine, University of Defense, Hradec Kralove, Czech Republic
700    1_
$a Hadzi Nikolov, Dimitar $u Department of Pathology, Regional Hospital, Kolin, Czech Republic
700    1_
$a Drösslerova, Marie $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Matej, Radoslav $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Rozsypalova, Aneta $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Richter, Igor $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic $u Department of Oncology, Regional Hospital, Liberec, Czech Republic
700    1_
$a Melichar, Bohuslav $u Department of Oncology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic
700    1_
$a Mahel, Rostislav $u ANOVA CRO Ltd., Prague, Czech Republic
700    1_
$a Stepanova, Radka $u ANOVA CRO Ltd., Prague, Czech Republic
700    1_
$a Lohynska, Radka $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Dvorak, Josef $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
773    0_
$w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 71, č. 6 (2024), s. 594-602
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39832204 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134742 $b ABA008
999    __
$a ok $b bmc $g 2311759 $s 1247660
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 71 $c 6 $d 594-602 $e - $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace